Home›People›Andrew Phillips
Andrew Phillips

Andrew Phillips

President and Chief Executive Officer, director at Nexo Therapeutics.

ExecutiveDirector
Updated Nov 10, 2026·Latest SEC filing Mar 27, 2026·Suggest an edit

About Andrew Phillips

Andrew Phillips is a president and chief executive officer, director at Nexo Therapeutics.

Andrew Phillips first appears on SEC filings in 2022.

Experience

This experience comes from SEC filings. The years are when the filings name Andrew Phillips in the role, so the role may have started earlier or lasted longer.

Nexo Therapeutics, Inc.
President and Chief Executive Officer, director
2022 – 2026 · Littleton, CO
Develops drugs for cancer patients with limited treatment options.

Key Colleagues at Startups

The people Andrew Phillips works with at each company, as listed on that company's latest Form D.

Nexo Therapeutics, Inc. · Form D/A, Mar 27, 2026
AB
Ali Behbahani
Partner, Co-Head of Healthcare, NEA and director
CR
Carlo Rizzuto
Managing Director, Versant Ventures

Sources

  1. SECNexo Therapeutics, Inc. Form D/A, filed Mar 27, 2026